Researcher
Veerle Mondelaers
- Disciplines:Endocrinology and metabolic diseases, Paediatrics and neonatology, Nursing
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → 25 Sep 2022 - Department of Pediatrics and medical genetics (Department)
Member
From19 Sep 2016 → 30 Sep 2018
Publications
1 - 10 of 22
- In vivo stabilization of a less toxic asparaginase variant leads to a durable anti-tumor response in acute leukemia(2023)
Authors: Maaike Van Trimpont, Amanda M. Schalk, Yanti De Visser, Hien Anh Nguyen, Lindy Reunes, Katrien Vandemeulebroecke, Evelien Peeters, Ying Su, Hyun Lee, Philip L. Lorenzi, et al.
Pages: 409 - 419 - Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols : a meta-analysis of the Ponte di Legno Toxicity working group(2022)
Authors: Leiah J. Brigitha, Marta Fiocco, Rob Pieters, Birgitte K. Albertsen, Gabriele Escherich, Elixabet Lopez-Lopez, Veerle Mondelaers, Ajay Vora, Lynda Vrooman, Kjeld Schmiegelow, et al.
Pages: 65 - 75 - Practice guidelines for the therapeutic drug monitoring of asparaginase in acute lymphoblastic leukemia(2022)
Authors: Veerle Mondelaers, Tim Lammens, Martijn de Jong, Larissa Deneweth, Katrien Vandemeulebroecke, Barbara De Moerloose
Pages: 236 - 242 - An atypical case of Burkitt lymphoma with diffuse peritoneal, omental and periportal invasion(2021)
Authors: E Claus, David Creytens, LUCAS MATTHYSSENS, Veerle Mondelaers, Nele Herregods
Pages: 46 - 51 - Intracranial myxoid mesenchymal tumor with EWSR1-CREB1 fusion(2020)
Authors: Sasha Libbrecht, Joni Van der Meulen, Veerle Mondelaers, Edward Baert, CAROLINE VANDE WALLE, Jo Van Dorpe, David Creytens
- Prospective, real-time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma in Belgium(2020)
Authors: Veerle Mondelaers, Alina Ferster, Anne Uyttebroeck, Benedicte Brichard, Juttevan der Werff ten Bosch, Koenraad Norga, Nadine Francotte, Caroline Piette, Katrien Vandemeulebroecke, Charlotte Verbeke, et al.
Pages: 105 - 114 - Recurrent arterial ischemic stroke with good response to mycophenolate mofetil(2019)
Authors: Benedikte Van Driessche, PATRICK VERLOO, Nele Herregods, Veerle Mondelaers, Jo Dehoorne, Rudy Van Coster, Helene Verhelst
Pages: 222 - 227 - A novel L-asparaginase with low L-glutaminase coactivity is highly efficacious against both T- and B-cell acute lymphoblastic leukemias in vivo(2018)
Authors: Hien Anh Nguyen, Ying Su, Jenny Yu Zhang, Aleksandar Antanasijevic, Michael Caffrey, Amanda M Schalk, Li Liu, Damiano Rondelli, Annie Oh, Dolores L Mahmud, et al.
Pages: 1549 - 1560 - Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951(2017)
Authors: Veerle Mondelaers, Stefan Suciu, Barbara De Moerloose, Alina Ferster, Francoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vitor Costa, et al.
Pages: 1727 - 1738 - Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia(2017)
Authors: Alessandro Casini, R Vilar, Y Beauverd, D Aslan, Katrien Devreese, Veerle Mondelaers, L Alberio, C Gubert, P de Moerloose, Marguerite Neerman-Arbez
Pages: 583 - 589